Amgen Company News

‘Community Day Presented by Amgen’ Mobilizes Volunteers to Touch Up Greater Los Angeles Ahead of FIFA World Cup 2026 - Amgen

‘Community Day Presented by Amgen’ Mobilizes Volunteers to Touch Up Greater Los Angeles Ahead of FIFA World Cup 2026 Amgen

Amgen pipeline’s next growth cycle: replacing its old blockbusters - Labiotech.eu

Amgen pipeline’s next growth cycle: replacing its old blockbusters Labiotech.eu

Morgan Stanley Raises Amgen (AMGN) Target Ahead of Q1, Truist Lifts Outlook on Pipeline Strength - Yahoo Finance

Morgan Stanley Raises Amgen (AMGN) Target Ahead of Q1, Truist Lifts Outlook on Pipeline Strength Yahoo Finance

Amgen builds commercial organisation for new product launches in the Netherlands - Consultancy.eu

Amgen builds commercial organisation for new product launches in the Netherlands Consultancy.eu

Amgen and BeOne Medicines get Chinese approval for small cell lung cancer drug - Mugglehead Investment Magazine

Amgen and BeOne Medicines get Chinese approval for small cell lung cancer drug Mugglehead Investment Magazine

Beat the Market the Zacks Way: FirstEnergy, Seanergy Maritime, Amgen in Focus - TradingView — Track All Markets

Beat the Market the Zacks Way: FirstEnergy, Seanergy Maritime, Amgen in Focus TradingView — Track All Markets

Amgen's lung cancer drug tarlatamab wins China approval - Reuters

Amgen's lung cancer drug tarlatamab wins China approval Reuters

AMGN Maintained by UBS -- Price Target Raised to $400 - GuruFocus

AMGN Maintained by UBS -- Price Target Raised to $400 GuruFocus

Amgen CEO netted $24.7M pay package in ‘25 as company’s upward trajectory continued - Fierce Pharma

Amgen CEO netted $24.7M pay package in ‘25 as company’s upward trajectory continued Fierce Pharma

Robeco Institutional Asset Management B.V. Increases Stake in Amgen Inc. $AMGN - MarketBeat

Robeco Institutional Asset Management B.V. Increases Stake in Amgen Inc. $AMGN MarketBeat

Amgen Settles Denosumab Biosimilar Lawsuits with Henlius and Organon - National Today

Amgen Settles Denosumab Biosimilar Lawsuits with Henlius and Organon National Today

Is It Time To Revisit Amgen (AMGN) After The Recent 4.6% Share Price Pullback - simplywall.st

Is It Time To Revisit Amgen (AMGN) After The Recent 4.6% Share Price Pullback simplywall.st

Amgen Inc. stock (US0311621009): Is obesity drug momentum strong enough to unlock new upside? - AD HOC NEWS

Amgen Inc. stock (US0311621009): Is obesity drug momentum strong enough to unlock new upside? AD HOC NEWS

Amgen Named One of the 2026 World’s Most Ethical Companies® by Ethisphere - Amgen

Amgen Named One of the 2026 World’s Most Ethical Companies® by Ethisphere Amgen

Sumitomo Mitsui Trust Group Inc. Has $527.74 Million Stock Position in Amgen Inc. $AMGN - MarketBeat

Sumitomo Mitsui Trust Group Inc. Has $527.74 Million Stock Position in Amgen Inc. $AMGN MarketBeat

Is Amgen (AMGN) One of the Most Profitable Value Stocks to Buy Right Now? - Yahoo Finance

Is Amgen (AMGN) One of the Most Profitable Value Stocks to Buy Right Now? Yahoo Finance

2025 at Amgen: Investing, Expanding, and Serving More Patients - Amgen

2025 at Amgen: Investing, Expanding, and Serving More Patients Amgen

Encompass Wealth Advisors LLC Sells 3,010 Shares of Amgen Inc. $AMGN - MarketBeat

Encompass Wealth Advisors LLC Sells 3,010 Shares of Amgen Inc. $AMGN MarketBeat

Highlights from Amgen's 2025 Fourth Quarter and Full Year Earnings Report - Amgen

Highlights from Amgen's 2025 Fourth Quarter and Full Year Earnings Report Amgen

Prime Capital Investment Advisors LLC Has $6.32 Million Stake in Amgen Inc. $AMGN - MarketBeat

Prime Capital Investment Advisors LLC Has $6.32 Million Stake in Amgen Inc. $AMGN MarketBeat

OFI Invest Asset Management Increases Stock Position in Amgen Inc. $AMGN - MarketBeat

OFI Invest Asset Management Increases Stock Position in Amgen Inc. $AMGN MarketBeat

Amgen Once Again Recognized as Top Pharma Company by U.S. Patients - Amgen

Amgen Once Again Recognized as Top Pharma Company by U.S. Patients Amgen

Amgen-Backed DLL3 Combo Trial Could Be A Game Changer For Zai Lab (ZLAB) - simplywall.st

Amgen-Backed DLL3 Combo Trial Could Be A Game Changer For Zai Lab (ZLAB) simplywall.st

Eli Lilly Vs. Amgen: Who Leads Obesity And IMIDs (NASDAQ:AMGN) - Seeking Alpha

Eli Lilly Vs. Amgen: Who Leads Obesity And IMIDs (NASDAQ:AMGN) Seeking Alpha

Bio Meets Tech: How Amgen is Designing the Medicines of Tomorrow - Amgen

Bio Meets Tech: How Amgen is Designing the Medicines of Tomorrow Amgen

Investors Heavily Search Amgen Inc. (AMGN): Here is What You Need to Know - Yahoo Finance

Investors Heavily Search Amgen Inc. (AMGN): Here is What You Need to Know Yahoo Finance

We Picked Amgen Stock a Year Ago. Stick With the Emerging GLP-1 Play. - Barron's

We Picked Amgen Stock a Year Ago. Stick With the Emerging GLP-1 Play. Barron's

Amgen’s Tarlatamab Approved in China - Pharmaceutical Executive

Amgen’s Tarlatamab Approved in China Pharmaceutical Executive

Curtis Advisory Group Adds Amgen Shares to Portfolio - National Today

Curtis Advisory Group Adds Amgen Shares to Portfolio National Today

Guggenheim raises Amgen stock price target to $351 on product mix - Investing.com

Guggenheim raises Amgen stock price target to $351 on product mix Investing.com

Amgen’s Subcutaneous TEPEZZA Data Sets New Gold Standard for Thyroid Eye Disease Treatment - The Chronicle-Journal

Amgen’s Subcutaneous TEPEZZA Data Sets New Gold Standard for Thyroid Eye Disease Treatment The Chronicle-Journal

Amgen Breaks Ground on $600 Million Center for Science and Innovation in Thousand Oaks, Calif. - Amgen

Amgen Breaks Ground on $600 Million Center for Science and Innovation in Thousand Oaks, Calif. Amgen

Amgen Named Official Biotech Partner by Los Angeles Sports & Entertainment Commission (LASEC) Ahead of FIFA World Cup 2026 - Amgen

Amgen Named Official Biotech Partner by Los Angeles Sports & Entertainment Commission (LASEC) Ahead of FIFA World Cup 2026 Amgen